Andreessen Horowitz

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

FidoCure is dedicated to advancing canine cancer care through the use of AI-driven precision medicine. The company has established the largest proprietary learning database for canine cancer by utilizing data from naturally occurring cases and next-generation sequencing. FidoCure focuses on providing personalized medicine services, which go beyond traditional chemotherapy and radiation. By collecting tissue samples for DNA sequencing, the company generates detailed reports that identify genetic mutations influencing treatment options. This approach enables veterinarians and pet owners to implement targeted therapies that specifically address cancer cells, ultimately improving the quality of life for dogs facing cancer. Furthermore, FidoCure bridges the gap between human and veterinary oncology, fostering comparative oncology and creating innovative drug development opportunities that benefit both pets and humans.

FidoCure is dedicated to advancing canine cancer care through the use of AI-driven precision medicine. The company has established the largest proprietary learning database for canine cancer by utilizing data from naturally occurring cases and next-generation sequencing. FidoCure focuses on providing personalized medicine services, which go beyond traditional chemotherapy and radiation. By collecting tissue samples for DNA sequencing, the company generates detailed reports that identify genetic mutations influencing treatment options. This approach enables veterinarians and pet owners to implement targeted therapies that specifically address cancer cells, ultimately improving the quality of life for dogs facing cancer. Furthermore, FidoCure bridges the gap between human and veterinary oncology, fostering comparative oncology and creating innovative drug development opportunities that benefit both pets and humans.